Home › Calculator › LAB Dividend Calculator 2026
LAB Dividend DRIP Calculator 2026
280.74% YieldHealthcareStandard BioTools Inc. · NASDAQ
Price: $0.71 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When LAB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your LAB snowball 📈
$10,000 in LAB → $14983168708052428.00M in 10 years · $1,248,163,216,812,478,800,000.00/month
About Standard BioTools Inc. (LAB) — Dividend Analysis 2026
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments. Its proteomics and genomics include instruments, consumables, and assays for clinical and diagnostic uses. The company also provides SomaScan platform that enables researchers to measure proteins simultaneously and provides deep insights into biological processes and disease mechanisms; CyTOF technology platform that uses metal-tagged antibodies and time-of-flight mass spectrometry to eliminate signal interference and expand multiplexing capabilities; Hyperion, a spatial biology platform, which unlocks deeper insights into tissue organization by preserving spatial context while enabling high-dimensional molecular and proteomic analysis; and Biomark X9 system that redefines high-throughput genomics for quantitative polymerase chain reaction applications. The company sells its instruments and consumables for research use only to academic research institutions, translational research and medicine centers, cancer centers, and clinical research laboratories, as well as biopharmaceutical, biotechnology, and plant and animal research companies. It has license agreements with California Institute of Technology, Harvard University, and Caliper Life Sciences, Inc. The company was formerly known as Fluidigm Corporation and changed its name to Standard BioTools Inc. in November 2001. Standard BioTools Inc. was incorporated in 1999 and is headquartered in Boston, Massachusetts.
Compare LAB with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full LAB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open LAB position with:
🌍 LAB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold LAB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 280.74% | 277.94% | $28,074 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 238.63% | 235.83% | $23,863 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 224.59% | 221.79% | $22,459 / yr |
| 🇬🇧 UK ISA | 0% | 280.74% | 277.94% | $28,074 / yr |
| 🇬🇧 UK Taxable | 8.75% | 256.18% | 253.38% | $25,618 / yr |
| 🇨🇦 TFSA | 0% | 280.74% | 277.94% | $28,074 / yr |
| 🇨🇦 CA Taxable | 25% | 210.56% | 207.75% | $21,056 / yr |
| 🇦🇺 Super (pension) | 15% | 238.63% | 235.83% | $23,863 / yr |
| 🇦🇺 AU Taxable | 30% | 196.52% | 193.72% | $19,652 / yr |
| 🇩🇪 DE Taxable | 26.375% | 206.69% | 203.89% | $20,669 / yr |
| 🇫🇷 FR Taxable | 30% | 196.52% | 193.72% | $19,652 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 LAB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 LAB Dividend Payment Schedule
LAB pays quarterly — 4 times per year. Next ex-div: TBD.
📊 LAB vs Healthcare Benchmarks
How LAB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for LAB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ LAB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-08-20 | 25,729 | $0.67 | $17.3K | ||
| F-InKind | 2026-08-20 | 28,195 | $0.67 | $18.9K | ||
| F-InKind | 2026-08-20 | 97,627 | $0.67 | $65.6K | ||
| F-InKind | 2026-08-03 | 362,625 | $0.87 | $314.8K | ||
| F-InKind | 2026-07-23 | 202,476 | $0.90 | $181.2K | ||
| A-Award | 2026-06-18 | 99,116 | — | — | ||
| A-Award | 2026-06-18 | 263,884 | $0.83 | $218.9K | ||
| A-Award | 2026-06-20 | 500,000 | — | — | ||
| A-Award | 2026-06-18 | 99,116 | — | — | ||
| A-Award | 2026-06-18 | 175,923 | $0.83 | $146.0K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where LAB earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the LAB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Standard BioTools Inc. (LAB) is currently trading at $0.71, 90% below its 52-week high. The current dividend yield is 280.74% based on an annual payout of $2.00 per share.
LAB (Standard BioTools Inc.) — 280.74% Dividend Yield Analysis
Standard BioTools Inc. (LAB) is a healthcare stock currently trading at $0.71 with a dividend yield of 280.74%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (280.74%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.